Trial Profile
Liraglutide Use in Prader-Willi Syndrome.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Prader-Willi syndrome; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 08 Dec 2015 Status changed from active, no longer recruiting to discontinued, as reported by ClinicalTrials.gov.
- 08 Mar 2012 New trial record